IRIS
FERRARI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.669
EU - Europa 2.967
AS - Asia 1.693
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
SA - Sud America 1
Totale 8.346
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.632
CN - Cina 1.224
IE - Irlanda 933
SE - Svezia 683
IT - Italia 470
TR - Turchia 340
FI - Finlandia 314
DE - Germania 218
FR - Francia 123
UA - Ucraina 80
SG - Singapore 71
CA - Canada 32
IN - India 26
DK - Danimarca 25
NL - Olanda 22
BE - Belgio 20
AT - Austria 16
GB - Regno Unito 14
RO - Romania 13
CZ - Repubblica Ceca 11
AU - Australia 8
ES - Italia 7
EU - Europa 5
CH - Svizzera 4
JP - Giappone 4
KR - Corea 4
MX - Messico 4
PK - Pakistan 4
TW - Taiwan 4
BD - Bangladesh 3
EE - Estonia 3
TH - Thailandia 3
BG - Bulgaria 2
HK - Hong Kong 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PL - Polonia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BR - Brasile 1
GL - Groenlandia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 8.346
Salva come PNG Salva come JPEG
Città #
Dublin 932
Chandler 729
Dearborn 409
Ashburn 350
Izmir 300
Nanjing 248
Beijing 229
Princeton 200
Ann Arbor 155
Wilmington 151
Parma 136
Jacksonville 105
New York 85
Helsinki 84
Shanghai 78
Hebei 74
Shenyang 72
Nanchang 64
Kunming 52
Seattle 48
Jinan 46
Tianjin 43
Grafing 42
Düsseldorf 41
Jiaxing 41
Bremen 39
Kocaeli 39
Changsha 37
Singapore 37
San Mateo 35
Hefei 34
Norwalk 34
Milan 31
Des Moines 30
Guangzhou 26
Taastrup 23
Bologna 21
Mestre 21
Toronto 21
Houston 20
Zhengzhou 19
Brussels 18
Boardman 17
Hangzhou 17
Pune 15
Stockholm 15
Vienna 15
Ardea 14
Ningbo 14
Washington 14
Los Angeles 13
Rockville 13
Fremont 12
Chicago 11
Montespertoli 11
Woodbridge 11
Borås 10
Chengdu 10
Fairfield 10
Falls Church 10
Fuzhou 9
Limena 9
Rome 9
Haikou 7
Redwood City 7
Focsani 6
Phoenix 6
Piacenza 6
Reggio Emilia 6
Edinburgh 5
Frankfurt am Main 5
Lanzhou 5
Taiyuan 5
Baotou 4
Cambridge 4
Lausanne 4
London 4
Lucca 4
Modena 4
Moncalieri 4
Sant'ilario D'enza 4
Shaoxing 4
Taizhou 4
Amsterdam 3
Atlanta 3
Bangkok 3
Binasco 3
Brooklyn 3
Cento 3
Chongqing 3
Cortemaggiore 3
Cumignano sul Naviglio 3
Leawood 3
Nepi 3
Pioltello 3
Pisa 3
Regina 3
San Jose 3
Santa Margherita Ligure 3
Sydney 3
Totale 5.607
Salva come PNG Salva come JPEG
Nome #
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 123
Metabolic regulation of the HBV-specific T cell function 76
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 76
Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study 74
Le linee di ricerca strategiche di un'azienda ospedaliero-universitaria: proposta di un metodo qualiquantitativo 72
Tiroiditi distruttive in pazienti affetti da epatite cronica attiva da virus C in terapia con interferone: nostra esperienza 72
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 72
A simplified sars-cov-2 pseudovirus neutralization assay 69
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 68
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 67
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 67
Alterazioni della funzionalità tiroidea in pazienti affetti da epatite cronica attiva da virus C in terapia con interferone e ribavirina e correlazione con la risposta alla terapia antivirale. 66
Adaptive immunity in HBV infection 66
ALTERAZIONI DELLA FUNZIONALITA’ TIROIDEA IN PAZIENTI AFFETTI DA EPATITE CRONICA ATTIVA DA VIRUS C IN TERAPIA CON INTERFERONE E RIBAVIRINA E CORRELAZIONE CON LA RISPOSTA ALLA TERAPIA ANTIVIRALE 65
What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group 65
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 65
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 64
Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV. J. Hepatol. 62
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 62
Graves Disease In Interferon - Treated and Untreated Patients with Chronic Hepatitis C Virus Infection 61
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B 61
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 61
The anti-COVID-19 vaccine unveils latent systemic sclerosis 60
T cell regulation in HBV-related chronic liver disease 60
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 59
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 58
Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection 58
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 57
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 56
Clinical spectrum of cryoglobulinaemic neuropathy 55
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 55
Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection 55
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 55
Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C? 54
Course of Graves' disease in interferon-treated patients with chronic hepatitis C virus infection and in uninfected patients 54
STUDIO E COMPARAZIONE DELLE ALTERAZIONI DI FUNZIONALITA’ TIROIDEA INDOTTE DA INTERFERONE NEI SOGGETTI CON EPATITE CRONICA ATTIVA DA VIRUS C RISPETTO A SOGGETTI DI CONTROLLO 54
Clinical features of hepatitis delta virus infection in a northern Italian area 54
Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. 54
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 53
[An outbreak type A hepatitis in a family group living in a village near Parma. Epidemiologic evaluation and prophylaxis (author's transl)] 53
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 53
Association of solid-phase assays to the indirect immunofluorescence in primary biliary cholangitis diagnosis: Results of an Italian multicenter study 53
HBV immune-therapy: From molecular mechanisms to clinical applications 52
Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C [5] 52
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 51
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 50
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 50
Role of viral and host factors in HCV persistence: Which lesson for therapeutic and preventive strategies? 50
New perspectives for T-cell-based HCV vaccines 50
T and B Cells in Hepatitis C Virus Control: What They Do and When They Fail 49
Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response 49
Fine specificity of the human T cell response to hepatitis B virus core antigen 49
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein 49
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 49
Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV 48
Immune pathogenesis of hepatitis B 48
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 47
Subacute thyroiditis after tick bite 47
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 46
Parenteral exposure to high HIV viremia leads to virus-specific T cell priming without evidence of infection 46
Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments 46
[The cell-mediated antiviral immune response. The possible therapeutic implications for chronic hepatitis B viral infection] 46
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 45
Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. 45
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 45
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B 45
Immunohistological characterization of lymph node in two cases of adult onset Still's disease 44
Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses 44
Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study 44
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope 44
Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. 44
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 44
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 44
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 44
Cellular immune response to hepatitis B virus antigens. An overview 43
Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at Day 0, Day 22, Day 29, and Week 6 [3] 43
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 43
T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection 43
Assessment of neutrophil gelatinase-associated lipocalin and lactate dehydrogenase in peritoneal fluids for the screening of bacterial peritonitis 43
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 42
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients 42
Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection 42
Innate and adaptive immune responses in chronic hepatitis B virus infections:Towards restoration of immune control of viral infection 42
The class I-restricted cytotoxic T lymphocyte response to predetermined epitopes in the hepatitis B and C viruses 42
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 42
Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines 42
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 42
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 42
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues 42
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 42
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells 41
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis 41
Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma. 41
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 41
Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection 41
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 41
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls 40
Hepatitis B virus immunopathology 40
The cellular immune response to nucleocapsid antigens in hepatitis B virus infection 40
Reorganization of a large academic hospital to face COVID-19 outbreak: The model of Parma, Emilia-Romagna region, Italy 40
Totale 5.233
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019433 0 0 0 0 0 0 0 0 0 8 351 74
2019/20201.665 439 180 46 28 108 350 185 50 103 109 35 32
2020/2021539 3 28 22 7 52 46 53 40 123 72 58 35
2021/2022816 23 17 7 48 74 58 47 88 48 26 30 350
2022/20233.180 406 247 168 205 222 361 43 188 1.126 16 142 56
2023/20241.188 81 144 60 76 121 349 92 119 59 87 0 0
Totale 8.682